COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2970: Articles 29691-29700  | Next

The Potential Use of Unprocessed Sample for RT-qPCR Detection of COVID-19 without an RNA Extraction Step
Arumugam, A., Wong, S. S.
10.1101/2020.04.06.028811 — Posted: 2020-04-08
Noisy Pooled PCR for Virus Testing
Zhu, J., Rivera, K., Baron, D.
10.1101/2020.04.06.026765 — Posted: 2020-04-08 Discussion: Offsite
LAMP-Seq: Population-Scale COVID-19 Diagnostics Using a Compressed Barcode Space
Schmid-Burgk, J. L., Li, D., Feldman, D., Slabicki, M., Borrajo, J., Strecker, J., Cleary, B., Regev, A., Zhang, F.
10.1101/2020.04.06.025635 — Posted: 2020-04-08 Discussion: Onsite
Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-CoV-2 RNA for COVID-19 Testing: Comparison of Formulated Lysis Buffers Containing 4 to 6 M GITC, Roche External Lysis Buffer and Qiagen RTL Lysis Buffer
Scallan, M. F., Dempsey, C., MacSharry, J., O'Callaghan, I., O'Connor, P. M., Hogan, C. P., Durack, E., Cotter, P. D., Hudson, S., Moynihan, H. A., Lucey, B.
10.1101/2020.04.05.026435 — Posted: 2020-04-08
Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro.
Yamamoto, N., Matsuyama, S., Hoshino, T., Yamamoto, N.
10.1101/2020.04.06.026476 — Posted: 2020-04-08 Discussion: Onsite
Mitigating COVID-19 outbreak via high testing capacity and strong transmission-intervention in the United States
Chen, S., Li, Q., Gao, S., Kang, Y., Shi, X.
10.1101/2020.04.03.20052720 — Posted: 2020-04-07
Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic
Worby, C. J., Chang, H.-H.
10.1101/2020.04.04.20052696 — Posted: 2020-04-07
The distress of Iranian adults during the Covid-19 pandemic - More distressed than the Chinese and with different predictors
Afshar Jahanshahi, A., Mokhtari Dinani, M., Nazarian Madavani, A., Li, J., Zhang, S. X.
10.1101/2020.04.03.20052571 — Posted: 2020-04-07 Discussion: Onsite
Community responses during early phase of the COVID-19 epidemic: a cross-sectional study
pourhaji, f., delshad, m. h., Pourhaji, F., Ghanbarizadeh, S. R., Azhdari Zarmehri, H., Bazrafshan, E., Gholian-Aval, M.
10.1101/2020.04.04.20053546 — Posted: 2020-04-07
Autocatalytic Model for Covid-19 Progression in a Country
Chernyshev, A.
10.1101/2020.04.03.20052985 — Posted: 2020-04-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).